APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer’s disease
- Author:
- No author available
- Journal Title:
- Neural Regeneration Research
- Issue:
- 6
- DOI:
- 10.4103/1673-5374.130117
- Key Word:
- nerve degeneration;cognitive disorders;dementia;Alzheimer’s disease;polymorphism;apolipoprotein E;apolipoprotein CI;low density lipoprotein receptor-related protein;NSFC grant;neural regeneration
Abstract： Current evidence shows that apolipoprotein E (APOE), apolipoprotein CI (APOC1) and low density lipoprotein receptor-related protein (LRP) variations are related to late-onset Alzheimer’s disease. However, it remains unclear if genetic polymorphisms in these genes are associated with cognitive decline in late-onset Alzheimer’s disease patients. We performed a 30-month longitudi-nal cohort study to investigate the relationship between Alzheimer’s disease and APOE, APOC1, and LRP. In this study, 78 Chinese Han patients with late-onset Alzheimer’s disease were recruit-ed form Guangxi Zhuang Autonomous Region in China. APOE, APOC1, and LRP genotyping was performed using polymerase chain reaction-restriction fragment length polymorphisms. The Mini-Mental State Examination and Clinical Dementia Rating Scale were used to assess pa-tients’ cognitive function. After a 30-month follow-up period, we found a signiifcant reduction in Mini-Mental State Examination total score, a higher proportion of patients fuliflling cognitive impairment progression criteria, and a higher proportion of APOC1 H2 carriers in APOEε4 carriers compared with non-carriers. In addition, the APOEε4 allele frequency was signiifcantly higher in the cognitive impairment progression group compared with the non-cognitive im-pairment progression group. In conclusion, APOEε4 plays an important role in augmenting cognitive decline, and APOC1 H2 may act synergistically with APOEε4 in increasing the risk of cognitive decline in Chinese patients with late-onset Alzheimer’s disease.
- [1]Kang D. E.,Saitoh T.,Chen X.,etc.Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease[J].1997.
- [2]Kok E,Haikonen S,Luoto T,etc.Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.[J].2009,65(6).
- [3]Hentz JG,Baxter LC,Reiman EM,etc.Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.[J].2004,62(11).
- [4]Crawford F,Mullan M,Fallin D,etc.No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample.[J].1997,233(2).
- [5]Richard J, Caselli,Eric M, Reiman,Dona E C, Locke,etc.Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.[J].2007,64(9).
- [6]Dudley,E.,Taurines,R.,Gerlach,M.,etc.Potential biomarkers in psychiatry: Focus on the cholesterol system[J].2012,16(6).
- [7]C J, Hong,T Y, Liu,H C, Liu,etc.Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population.[J].1996,46.
- [8]Meng,X.,D'Arcy,C..Apolipoprotein e gene, environmental risk factors, and their interactions in dementia among seniors[J].2013,28(10).
- [9]Basak JM,Holtzman DM,Kim J.The role of apolipoprotein E in Alzheimer's disease.[J].2009,63(3).
- [10]Hoek FJ,Lutjohann D,De Vente J,etc.Human apolipoprotein C-I expression in mice impairs learning and memory functions[J].2008,49(4).
- [11]Kong,A.,Giegling,I.,Thorsteinsdottir,U.,etc.Variant of TREM2 associated with the risk of Alzheimer's disease[J].2013,368(2).
- [12]Jun-Peng, Zhuang,Gang, Wang,Qi, Cheng,etc.Cognitive impairment and the associated risk factors among the elderly in the Shanghai urban area: a pilot study from China.[J].2012,1(1).
- [13]Kurz A,Perneczky R,Drzezga A,etc.Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.[J].2009,72(17).
- [14]Cuzzo LM,Ross Cisneros FN,Yee KM,etc.Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease.[J].2011,31(2).
- [15]Ferrell RE,DeKosky ST,Kamboh MI.Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.[J].1998,244(2).
- [16]W J, Strittmatter,A M, Saunders,D, Schmechel,etc.Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.[J].1993,90.
- [17]W.M.Nillesen,H.J.M.Smeets,B.A.van Oost.Human ApoCI Hpal restriction site polymorphism revealed by the polymerase chain reaction[J].1990,18(11).
- [18]Agneta Nordberg,Stephen F. Carter,Juha Rinne,etc.A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease[J].2013,40(1).
- [19]Li,W.,Cheng,Z.,Jin,C.,etc.Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: A meta-analysis[J].2012,527(1).
- [20]Stern Y,Craft S,Jack CR Jr,etc.Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.[J].2011,7(3).
- [21]Chan P,Zhou YT,Zhang ZX.Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han population.[J].2008,444(1).
- [22]Barnes DE,Yaffe K.The projected effect of risk factor reduction on Alzheimer's disease prevalence.[J].2011,10(9).
- [23]Verhey FR,Visser PJ,Ramakers IH,etc.Predictive value of APOE-epsilon4 allele for progression from MCI to AD-type dementia: a meta-analysis.[J].2011,82(10).
- [24]K, Kontula,K, Aalto-Set?l,T, Kuusi,etc.Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing.[J].1990,36(12).
- [25]Chia-Chan Liu,Takahisa Kanekiyo,Huaxi Xu Guojun Bu.Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy[J].2013,(Aug.).
- [26]Bangen,K.J.,Beiser,A.,Delano-Wood,L.,etc.APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline[J].2013,22(8).
- [27]C P, Hughes,L, Berg,W L, Danziger,etc.A new clinical scale for the staging of dementia.[J].1982,140.
- [28]Verghese PB,Castellano JM,Holtzman DM.Apolipoprotein E in Alzheimer's disease and other neurological disorders.[J].2011,10(3).
- [29]Jonathan Rosand,Scott L Silliman,Jaume Roquer,etc.Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage.[J].2013,44(6).
- [30]Craddock NJ,Morris JC,Goate AM,etc.Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population.[J].1997,222(3).
- [31]J L, Cummings.Mini-Mental State Examination. Norms, normals, and numbers.[J].1993,269(18).